Whole-exome sequencing studies have already uncovered some cancer drivers in chronic lymphocytic leukaemia (CLL) and have provided insights in disease pathogenesis, evolution and prognostication. At the 2015 annual EHA meeting in Vienna, Prof. Dr. Eugen Tausch (Universität Ulm) presented data of whole-exome sequencing of samples of 278 patients in the CLL8 trial.
(BELG J HEMATOL 2015;6(3):96–7)
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Hematology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Hematology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Hematology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
